Abstract
This study aimed to explore the therapeutic effects of Dendrobium officinale polysaccharide (DOP), an active ingredient isolated from the water extract of Dendrobium officinale, in streptozotocin (STZ)-induced type 2 diabetic BALB/c mice and its potential mechanisms. Our results showed that DOP had beneficial effects in ameliorating hyperglycemia, insulin resistance and dyslipidemia. Additionally, DOP promoted glycogen synthesis via regulating the expression of glycogen synthase kinase 3 beta (GSK-3β), glycogen synthase (GS) and glucose transporter 4 (GLUT4) in the liver or muscle. Moreover, DOP reduced the blood glucose levels via the regulation of glucose metabolizing enzyme activity including pyruvate kinase (PK), hexokinase (HK) and phosphoenolpyruvate carboxykinase (PEPCK) in the liver. Furthermore, mechanistic studies illustrated that DOP could up-regulate the expression of PI3K/Akt signaling proteins both in vivo and in vitro. Our findings revealed that DOP improves glucose metabolism disorder by promoting glycogen synthesis and regulating the activity of glucose metabolism enzymes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
